Dr. Bota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1640 Newport Blvd
Ste 400
Costa Mesa, CA 92627Phone+1 949-999-2400Fax+1 949-999-2405
Summary
- Dr. Daniela Bota is a Neurological Oncologist in Irvine, CA and is affiliated with UCI Medical Center. She received her medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice 20 years. She specializes in neurooncology and is experienced in neuro-oncology, gliomas, primary brain tumors, and antineoplastic agents.
Education & Training
- Duke University HospitalFellowship, Neurologic Oncology, 2006 - 2007
- University of Kansas School of MedicineResidency, Neurology, 2003 - 2006
- Carol Davila University of Medicine and PharmacyClass of 1997
Certifications & Licensure
- CA State Medical License 2007 - 2025
- NC State Medical License 2006 - 2008
- American Board of Psychiatry and Neurology Neurology
- AOA Board of Neurology and Psychiatry Neurology
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database Start of enrollment: 2005 Aug 04
- Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsMarizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih
Neuro-Oncology. 2024-09-05 - Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma.Steven Du, Dan Beverly Fu, Daniela A Bota, Xiao-Tang Kong
CNS Oncology. 2024-06-06 - 1 citationsCisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity.Naomi Lomeli, Diana C Pearre, Maureen Cruz, Kaijun Di, Joni L Ricks-Oddie
Experimental Neurology. 2024-05-01
Press Mentions
- Cell and Gene Therapies Symposium Open to PublicOctober 24th, 2024
- With Award of $8 Million, UC Irvine and Regional Partners Will Expand Stem Cell TreatmentsOctober 31st, 2022
- UCI Earns Designation as CIRM Alpha Clinic with Five-Year, $8 Million GrantOctober 27th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: